Apparicine is primarily investigated for its potential anticancer properties. It has shown activity in inhibiting the growth of certain tumor cell lines, making it a subject of interest in oncology research. Studies suggest it may interfere with cell proliferation and induce apoptosis in cancer cells, particularly in models of leukemia and solid tumors. Due to its natural origin and structural complexity, apparicine also serves as a lead compound in the development of novel chemotherapeutic agents. Its application remains largely in the preclinical research phase, with ongoing efforts to optimize its efficacy and understand its mechanism of action.